Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $870 | $862 | $861 | $0 |
| - Cash | $304 | $304 | $217 | $195 |
| + Debt | $244 | $244 | $227 | $247 |
| Enterprise Value | $810 | $802 | $871 | $53 |
| Revenue | $347 | $347 | $371 | – |
| % Growth | 0% | -6.3% | – | – |
| Gross Profit | $180 | $180 | $201 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| EBITDA | $69 | $69 | $41 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |
| Net Income | $34 | $34 | $15 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| Operating Cash Flow | $92 | $92 | $92 | – |
| Capital Expenditures | -$5 | -$5 | -$16 | – |
| Free Cash Flow | $87 | $87 | $75 | – |